Skip to main navigation Skip to search Skip to main content

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/MH/277 (ERM Project ID 43132)
NMA SSA Reference Number: SSA/43132/MonH-2019-171092(v1)
Monash Health Ref: RES-19-0000-300X
StatusFinished
Effective start/end date1/07/19 → 30/06/24

Keywords

  • clinical trial
  • stroke
  • treatment efficacy
  • Infarction

Clinical Trial Phase

  • Phase III (a & b)